Production (Stage)
Eledon Pharmaceuticals, Inc.
ELDN
$2.87
-$0.13-4.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 124.88M | 140.18M | 78.19M | 83.61M | 42.86M |
| Total Receivables | 761.00K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.02M | 6.38M | 2.88M | 3.45M | 5.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 55.00K | 729.00K | 442.00K | 157.00K | 54.00K |
| Total Current Assets | 127.72M | 143.73M | 81.51M | 87.22M | 47.98M |
|
|
|||||
| Total Current Assets | 127.72M | 143.73M | 81.51M | 87.22M | 47.98M |
| Net Property, Plant & Equipment | 850.00K | 926.00K | 471.00K | 621.00K | 270.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 354.00K | 363.00K | 210.00K | 255.00K | 185.00K |
| Total Assets | 161.31M | 177.41M | 114.58M | 120.48M | 80.82M |
|
|
|||||
| Total Accounts Payable | 2.90M | 5.83M | 5.86M | 2.15M | 1.86M |
| Total Accrued Expenses | 5.96M | 5.43M | 6.44M | 3.61M | 2.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 325.00K | 314.00K | 186.00K | 269.00K | 284.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.19M | 11.58M | 12.49M | 6.03M | 4.25M |
|
|
|||||
| Total Current Liabilities | 9.19M | 11.58M | 12.49M | 6.03M | 4.25M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 555.00K | 640.00K | 315.00K | 386.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 36.99M | 47.05M | 25.71M | 122.57M | 91.30M |
| Total Liabilities | 46.73M | 59.27M | 38.52M | 128.98M | 95.55M |
|
|
|||||
| Common Stock & APIC | 476.68M | 473.70M | 386.93M | 379.44M | 328.31M |
| Retained Earnings | -362.08M | -355.59M | -310.97M | -387.94M | -343.03M |
| Treasury Stock & Other | -18.00K | 26.00K | 102.00K | -- | -- |
| Total Common Equity | 114.58M | 118.14M | 76.06M | -8.50M | -14.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 114.58M | 118.14M | 76.06M | -8.50M | -14.73M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 114.58M | 118.14M | 76.06M | -8.50M | -14.73M |
|
|
|||||